About Careers MedBlog Contact us

Doctors Must Know Effectiveness of a Drug to Overpower Drug-Resisting Pathogens

by Julia Samuel on May 19, 2015 at 3:29 PM
Font : A-A+

Doctors Must Know Effectiveness of a Drug to Overpower Drug-Resisting Pathogens

Prescribing combination of drugs that reach similar parts of the body instead of just one could be an effective way of combating pathogens such as viruses or bacteria. Not all drugs can reach all parts of the body, a situation known as "imperfect drug penetration".

Researchers found that when there is a "pocket" of the body where only one drug is present, such as the brain or the digestive system, a pathogen can quickly develop resistance to one drug at a time.


"If there is a space where there is only one drug, that is the place where the pathogen can start its escape," said co-author of the study Pleuni Pennings, Assistant Professor of biology, San Francisco State University. "Once it no longer has the first drug to deal with, it is very easy for it to quickly become resistant to a second drug," Pennings said.

The study could have major implications for how treatment plans are designed and prescribed to patients of HIV, malaria, tuberculosis and other ailments.

Because pathogens can quickly develop resistance to a single drug, providers often prescribe multiple drugs to increase their effectiveness.

The results of the study suggest that, when doing so, doctors should carefully consider which parts of the body each drug will reach.

Source: Medindia


Recommended Reading

Latest Drug News

 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Price Cap Move Will Place Eli Lilly Strongly in Insulin Market
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Doctors Must Know Effectiveness of a Drug to Overpower Drug-Resisting Pathogens Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests